About Dried Yeast Fermentate (EpiCor)
Dried fermentate of Saccharomyces cerevisiae (branded EpiCor), studied in several placebo-controlled human RCTs for immune support (reduced cold/flu-like symptom days, antibody response) at 500mg/day. Most trials are funded/sponsored by the ingredient manufacturer (Cargill); no independent meta-analysis exists yet.
What Dried Yeast Fermentate (EpiCor) supports
- Multiple RCTs (largely industry-funded) suggest reduced cold/flu-like symptom days with daily use
How much Dried Yeast Fermentate (EpiCor) to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
500–500
mg
500 mg/day is the dose used in most published EpiCor immune-support RCTs.
Clinical evidence
Moderate clinical evidence. Several positive RCTs, but most are manufacturer-funded; no independent meta-analysis yet.
NIH Fact Sheet